Long Lasting Effect of Hyperbaric Oxygen Therapy on Cognitive Function in Traumatic Brain Injury Patients
Assaf-Harofeh Medical Center
100 participants
Dec 28, 2021
OBSERVATIONAL
Conditions
Summary
Purpose of the trial, rationale including definition of quantitative measures and description of participant recruitment: Background and rationale: Traumatic brain injury (TBI) is one of the most common causes of disability and death in the general population \[1\]. Recent studies have shown that hyperbaric oxygen therapy helps improve cognitive function and quality of life in patients with chronic neurological deficits after traumatic brain injury of various severities, due to changes in brain neuroplasticity \[2-4\]. To date, only a few studies have examined the sustained effect of hyperbaric therapy on somatic, cognitive, or emotional symptoms in this population. Only two studies examined persistent effects in the range of 6 to 12 months after the end of a series of treatments \[5-6\]. Study objective: The aim of the current study is to evaluate the cognitive functions of patients who suffered brain injury due to traumatic head injury and were previously treated in a hyperbaric chamber between one and four years after the end of treatment.
Eligibility
Inclusion Criteria4
- Diagnosed with traumatic brain injury
- Age 18 years or older at treatment
- Completed a 60 session hyperbaric treatment course at the Sagol Center for Hyperbaric Medicine and Research, Shamir Medical Center (Assaf Harofeh), and performed a neurocognitive evaluation by the computerized test Neurotrax.
- Willing and able to sign an informed consent. -
Exclusion Criteria5
- An inability to perform a neurocognitive computerized test.
- Any head trauma, neurodegenerative diseases or CVA after hyperbaric treatment completion.
- Diagnosis of a psychiatric disorder including: major depression, schizophrenia, bipolar disorder
- Active malignancy
- Chronic use of medications that may compromise cognitive function
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07430150